ZyCoV-D shot can remain stable at room temperature: Zydus Cadila chairman

The company plans to apply for approval once it finishes phase 3 trials

Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila), which is readying to start phase 3 clinical trials, claimed that its investigational candidate ZyCoV-D can remain stable even at room temperature for at least three months.

Speaking at a FICCI event, Pankaj Patel, chairman of Zydus Cadila said, "We feel this is a very stable vaccine and would not even need 2 to 8 degrees temperature, but can remain stable even at 30 degree Celsius for about three months at least." At a cold chain temperature of 2 to 8 degrees, this can be stable for even longer.

This can be a